30 Jan, 10:34 - Indian

SENSEX 76858.73 (0.43)

Nifty 50 23290.9 (0.55)

Nifty Bank 49339.85 (0.35)

Nifty IT 42895.8 (-0.04)

Nifty Midcap 100 52984.65 (0.50)

Nifty Next 50 62563.3 (0.68)

Nifty Pharma 21373.95 (0.99)

Nifty Smallcap 100 16719.1 (1.08)

30 Jan, 10:34 - Global

NIKKEI 225 39437.68 (0.06)

HANG SENG 20225.11 (0.14)

S&P 6099.5 (0.33)

Login/Signup
LOGIN HERE
Cancel

companylogoAarey Drugs & Pharmaceuticals Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 524412 | NSE Symbol : AAREYDRUGS | ISIN : INE198H01019 | Industry : Pharmaceuticals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
02-Jan-2025 02-Jan-2025 Change in Other Executives Reg 30 of SEBI (Listing Obligation and Disclosure Requirements)- Resignation of Company Secretary
29-Nov-2024 04-Dec-2024 Increase in Authorised Capital AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/12/2024 inter alia to consider and approve Raising funds by way of Preferential issue of shares or warrants or any other method Outcome (As per BSE Announcement Dated on 04/12/2024)
26-Nov-2024 29-Nov-2024 Preferential Issue AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/11/2024 inter alia to consider and approve Preferential issue or any other matter outcome (As Per BSE Announcement Dated on 29.11.2024)
06-Nov-2024 14-Nov-2024 Quarterly Results AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Financial result for september 2024 Outcome (As per BSE Announcement dated on 14/11/2024)
25-Sep-2024 01-Oct-2024 Conversion AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/10/2024 inter alia to consider and approve Allotment Outcome (As Per BSE Announcement Dated on: 01/10/2024)
06-Aug-2024 14-Aug-2024 Quarterly Results AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited Financial Result for June 2024 outcome (As per BSE Announcement Dated on 14/08/2024)
23-May-2024 30-May-2024 Accounts AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve Financial Audited Result of March 2024 outcome (As Per BSE Announcement Dated on 30.05.2024)
20-Mar-2024 27-Mar-2024 Preferential Issue AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2024 inter alia to consider and approve Allotment of Equity Shares and Warrants Outcome of Board Meeting Allotment of Securities (As Per BSE Announcement dated on 27.03.2024)
06-Feb-2024 14-Feb-2024 Quarterly Results AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Unaudited Financial result. Outcome Unaudited financial Result for december 2023 (As Per BSE Announcement Dated on: 14/02/2024)
04-Nov-2023 11-Nov-2023 Quarterly Results AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 inter alia to consider and approve Unaudited Financial result for September. 2023 Outcome (As Per BSE Announcement dated on 11.11.2023)
09-Oct-2023 09-Oct-2023 Change in Directors Outcome for appointment and resignation
05-Aug-2023 14-Aug-2023 Quarterly Results AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve June 2023 unaudited financial result June 2023 unaudited financial result Outcome (As Per BSE Announcement Dated on 14.08.2023)
07-Aug-2023 10-Aug-2023 Increase in Authorised Capital AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve issue of raising funds Increase in Authorised Capital & Issue Of Warrants & Preferential Issue of shares (As per BSE Bulletin dated on 07/08/2023) Outcome Announcement under Regulation 30(LODR) (As Per BSE Announcement dated on 10.08.2023)
26-Jul-2023 31-Jul-2023 Raising funds through Debt Instr. AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2023 inter alia to consider and approve raising of funds. Outcome Announcement under Regulation 30 (As Per BSE Announcement dated on 31.07.2023)
19-Jun-2023 21-Jun-2023 Preferential Issue Preferential Issue of shares & Increase in Authorised Capital Outcome of Board Meeting. (As per BSE Announcement Dated on 21/06/2023)
1 2 3 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-9769005430
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
+91-8657545825  

subscription@capitalmarket.com

For Capital Market Online Product related queries :
+91-8657545825  

financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +